Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Hetrombopag Diolamine
2. 1257792-42-9
3. Shr8735 Olamine
4. Hetrombopag Ethanolamine
5. Shr-8735 Olamine
6. V45t2i862x
7. Unii-v45t2i862x
8. (z)-5-(2-hydroxy-3-(2- (3-methyl-5-oxo-1-(5,6,7,8-tetrahydronaphthalen- 2-yl)-1h-pyrazol-4(5h)-ylidene)hydrazinyl)phenyl) Furan-2-carboxylic Acid Diethanolamine
9. Rafutrombopag Diolamine
10. Rafutrombopag Olamine
11. Orb1986927
12. Schembl1706508
13. Schembl1706884
14. Schembl31679698
15. Glxc-10341
16. Hetrombopag Olamine [who-dd]
17. Akos040748526
18. Da-77338
19. Q27291517
20. 2-aminoethanol 5-{2-hydroxy-3-[5-methyl-3-oxo-2-(5,6,7,8-tetrahydro-naphthalen-2-yl)-2,3-dihydro-1h-pyrazol-4-ylazo]-phenyl}-furan-2-carboxylic Acid
21. 2-aminoethanol;5-[2-hydroxy-3-[[5-methyl-3-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1h-pyrazol-4-yl]diazenyl]phenyl]furan-2-carboxylic Acid
| Molecular Weight | 580.6 g/mol |
|---|---|
| Molecular Formula | C29H36N6O7 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 220 |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 870 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
93
PharmaCompass offers a list of Hetrombopag olamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hetrombopag olamine manufacturer or Hetrombopag olamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hetrombopag olamine manufacturer or Hetrombopag olamine supplier.
A Hetrombopag olamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hetrombopag olamine, including repackagers and relabelers. The FDA regulates Hetrombopag olamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hetrombopag olamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hetrombopag olamine supplier is an individual or a company that provides Hetrombopag olamine active pharmaceutical ingredient (API) or Hetrombopag olamine finished formulations upon request. The Hetrombopag olamine suppliers may include Hetrombopag olamine API manufacturers, exporters, distributors and traders.
Hetrombopag olamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hetrombopag olamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hetrombopag olamine GMP manufacturer or Hetrombopag olamine GMP API supplier for your needs.
A Hetrombopag olamine CoA (Certificate of Analysis) is a formal document that attests to Hetrombopag olamine's compliance with Hetrombopag olamine specifications and serves as a tool for batch-level quality control.
Hetrombopag olamine CoA mostly includes findings from lab analyses of a specific batch. For each Hetrombopag olamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hetrombopag olamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Hetrombopag olamine EP), Hetrombopag olamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hetrombopag olamine USP).
